Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence-Reference-Cited by-同舟云学术

Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence

Published:2021-12-08 Issue:1 Volume:25 Page:26-37
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Udayachalerm Sariya¹^ORCID,Renouard Maranda G.¹,Anothaisintawee Thunyarat²^ORCID,Thakkinstian Ammarin³^ORCID,Veettil Sajesh K.¹^ORCID,Chaiyakunapruk Nathorn¹⁴^ORCID

Affiliation:

1. University of Utah College of Pharmacy, Salt Lake City, UT, USA

2. Department of Family Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

3. Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

4. School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2021.2008195

Reference71 articles.

1. Systematic review of incidence and complications of herpes zoster: towards a global perspective

2. The global epidemiology of herpes zoster

3. Herpes Zoster

4. Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013

5. null

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protecting patients with SLE against herpes zoster: time for early proactive vaccine counselling;The Lancet Rheumatology;2024-06

2. Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older;PharmacoEconomics - Open;2024-04-11

3. Time to talk to adults with rheumatic diseases about herpes zoster vaccination;The Lancet Rheumatology;2024-04

4. Incremental net monetary benefit of biologic therapies in moderate to severe asthma: a systematic review and meta-analysis of economic evaluation studies;Journal of Asthma;2023-03-16

5. Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review;Human Vaccines & Immunotherapeutics;2023-01-02